Cargando…

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis

BACKGROUND: Severe COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, the effect of dexamethasone treatment on cardiac i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jirak, Peter, van Almsick, Vincent, Dimitroulis, Dimitrios, Mirna, Moritz, Seelmaier, Clemens, Shomanova, Zornitsa, Wernly, Bernhard, Semo, Dilvin, Dankl, Daniel, Mahringer, Magdalena, Lichtenauer, Michael, Hoppe, Uta C., Reinecke, Holger, Pistulli, Rudin, Larbig, Robert, Motloch, Lukas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847392/ https://www.ncbi.nlm.nih.gov/pubmed/35186995 http://dx.doi.org/10.3389/fmed.2022.808221

Ejemplares similares

Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
por: Jirak, Peter, et al.
Publicado: (2021)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
por: Ohnewein, Bernhard, et al.
Publicado: (2023)

Higher incidence of stroke in severe COVID-19 is not associated with a higher burden of arrhythmias: comparison to other types of severe pneumonia
por: Jirak, P, et al.
Publicado: (2021)

Myocardial injury in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
por: Jirak, Peter, et al.
Publicado: (2020)

Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death
por: Shomanova, Zornitsa, et al.
Publicado: (2020)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020)

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
por: Rezar, Richard, et al.
Publicado: (2021)

Assessment of Cardiac Remodeling—A Chance for Novel Cardiac Biomarkers?
por: Jirak, Peter, et al.
Publicado: (2020)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure
por: Jirak, Peter, et al.
Publicado: (2017)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Hyperlactatemia and altered lactate kinetics are associated with excess mortality in sepsis: A multicenter retrospective observational study
por: Rezar, Richard, et al.
Publicado: (2022)

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
por: Rezar, Richard, et al.
Publicado: (2022)

Mortality after cardiopulmonary resuscitation on a medical ICU: A sex-specific outcome analysis
por: Rezar, Richard, et al.
Publicado: (2021)

Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
por: Boxhammer, Elke, et al.
Publicado: (2023)

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review
por: Topf, Albert, et al.
Publicado: (2021)

Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis: Review and meta-analysis
por: Rezar, Richard, et al.
Publicado: (2020)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022)

Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?
por: Rezar, Richard, et al.
Publicado: (2020)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
por: Fiedler, Lukas, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
por: Motloch, Lukas J., et al.
Publicado: (2022)

Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease
por: Edlinger, Christoph, et al.
Publicado: (2018)

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
por: Topf, Albert, et al.
Publicado: (2022)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism – A review and a case report
por: Topf, Albert, et al.
Publicado: (2021)

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
por: Motloch, Lukas J., et al.
Publicado: (2022)

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
por: Fiedler, Lukas, et al.
Publicado: (2023)

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
por: Schernthaner, Christiana, et al.
Publicado: (2017)

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
por: Topf, Albert, et al.
Publicado: (2022)

Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction
por: Kopp, Kristen, et al.
Publicado: (2023)

Management of intoxicated patients – a descriptive outcome analysis of 4,267 ICU patients
por: Rezar, Richard, et al.
Publicado: (2022)

Regenerative Cardiovascular Therapies: Stem Cells and Beyond
por: Wernly, Bernhard, et al.
Publicado: (2019)

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
por: Mirna, Moritz, et al.
Publicado: (2021)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
por: Topf, Albert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bacj2c1cpusp6rkk4bd926rlik